Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab and Gemcitabine in Advanced Pancreatic Cancer
NCT00561990Phase 3Completed
- Sponsor
- Oncoscience AG
- Start
- Sep 2007
- Primary completion
- Jan 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of nimotuzumab in pancreatic cancer (PC), sponsored by Oncoscience AG. Started Sep 2007; status: completed.
02
Drugs
nimotuzumab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00561990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561990.